Key Developments: ERBA Diagnostics Inc (ERB.A)

ERB.A on American Stock Exchange

2.45USD
3:58pm EDT
Price Change (% chg)

$0.17 (+7.46%)
Prev Close
$2.28
Open
$2.40
Day's High
$2.64
Day's Low
$2.35
Volume
19,077
Avg. Vol
3,849
52-wk High
$4.06
52-wk Low
$0.75

Search Stocks

Latest Key Developments (Source: Significant Developments)

ERBA Diagnostics Inc appoints Mohan Gopalkrishnan as Chief Executive Officer
Tuesday, 27 May 2014 04:30pm EDT 

ERBA Diagnostics Inc:Appoints Mohan Gopalkrishnan as Chief Executive Officer effective as of June 1.Sanjiv Suri, the Interim Chief Executive Officer of ERBA Diagnostics has delivered notice to the Company of his intention to resign, effective as of June 1.  Full Article

ERBA Diagnostics announces delay in filing annual report on Form 10-K
Monday, 31 Mar 2014 08:25am EDT 

ERBA Diagnostics Inc:Announced delaying the filing of Annual Report on Form 10-K for the year ended Dec. 31, 2013 with the Securities and Exchange Commission.Reason being unforeseen delays in connection with completing and filing consolidated financial statements and accompanying footnotes, which include ERBA Diagnostics' recently acquired subsidiaries - Drew Scientific, Inc. and JAS Diagnostics, Inc.  Full Article

ERBA Diagnostics Inc Diagnostics Sets Up Subsidiary In Mexico
Monday, 4 Nov 2013 08:00am EST 

ERBA Diagnostics Inc announced the opening of its wholly-owned subsidiary, ERBA Diagnostics Mexico S.A., located in Mexico City. This new subsidiary is ERBA Diagnostics' fifth wholly-owned subsidiary.  Full Article

ERBA Diagnostics Inc Announces Management Change-Form 8-K
Thursday, 11 Jul 2013 05:17pm EDT 

ERBA Diagnostics Inc reported in its Form 8-K that on July 6, 2013, Kevin Clark, the President, Chief Executive Officer (CEO) and Chief Operating Officer of ERBA Diagnostics, Inc. (Company), delivered notice to the Company of his intention to resign effective as of July 31, 2013. Effective as of August 1, 2013, Sanjiv Suri will become the Interim Chief Executive Officer (CEO) of the Company. Mr. Suri, has served as a Director on the Company‚Äôs Board of Directors since May 8, 2013, and he plans to continue in that role.  Full Article

ERBA Diagnostics Inc Announces Delay In Filing Annual Report On Form 10-K
Wednesday, 17 Apr 2013 08:41am EDT 

ERBA Diagnostics Inc announced that it is delaying the filing of Annual Report on Form 10-K for the year ended December 31, 2012 with the Securities and Exchange Commission (the SEC). As previously disclosed in the Notification of Late Filing on Form 12b-25, which ERBA Diagnostics filed with the SEC on April 2, 2013, ERBA Diagnostics delayed filing Annual Report on Form 10-K because of unforeseen delays in connection with completing and filing consolidated financial statements and the accompanying footnotes, which include ERBA Diagnostics` recently acquired subsidiaries - Drew Scientific, Inc., JAS Diagnostics, Inc. and Drew Scientific Limited Co. Until these matters can be resolved, ERBA Diagnostics will not be in a position to file Annual Report on Form 10-K with the SEC.  Full Article

ERBA Diagnostics Inc Acquires Escalon Medical Corp's Clinical Diagnostics Business
Thursday, 4 Oct 2012 08:00am EDT 

ERBA Diagnostics Inc announced that it has acquired from Escalon Medical Corp. its Clinical Diagnostics Business for $6.5 million in cash. The Escalon Clinical Diagnostics Business (ECD) consists of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. (JAS) and Drew Scientific Limited Co. ERBA funded the acquisition through proceeds from an additional investment of ERBA Mannheim GmbH in ERBA Common Stock.  Full Article

Search Stocks